Workforce highlighted how the Penn Mutual Life Insurance Company is offering the Cancer Guardian Comprehensive Cancer Support program “…to its 1,000-plus associates as a supplemental, employer-paid benefit, available to associates regardless of if they’re on Penn Mutual’s health plan.”
Read the article: Wamberg Genomic Advisors Executive VP, Sales & Business Development Nick Bellanca is featured on the Councilcast podcast talking about how genomic medicine is evolving healthcare. Listen to the Podcast
Read the article: Wamberg Genomic Advisors Executive VP, Sales & Business Development Nick Bellanca talks with Leader’s Edge Magazine about genetic products and services as part of employer benefit packages. Read The Q & A
Healthcare executives understand that cancer patients and their families are going through a difficult and challenging time. During this period, providing patients with access to guidance from knowledgeable experts can go a long way toward easing their frustrations.
Report reveals findings of surveyed cancer patients indicating that all do not have fast access to the most effective treatments, plus a need for more professional support and guidance from diagnosis through treatment
Tom Wamberg, the company’s chief executive officer, talked about his company during a recent interview in New York. Wamberg attended a LIMRA conference in an effort to persuade life insurers to add the company’s Cancer Guardian service package as a standard or add-on feature.
Wamberg Genomic Advisors was mentioned in the January 14-20, 2019 issue of the San Diego Business Journal, in the cover article, CATCHING UP TO CARE. “Genomics bleeding into insurance has given rise to firms with a foot in both worlds. Wamberg Genomic Advisors in La Jolla is one. ‘We found there was a need to […]